China Digest: Deepwise secures $17.3m series A+; WeDoctor invests in Halove

Deepwise, a clinical imaging services provider, raises a $17.3-million series A+ round led by Danhua Capital. Meanwhile, online healthcare consultancy giant WeDoctor Group joins the series A round of Halove, a healthcare hardware and software developer.

Deepwise secures $17.3m series A+

Deepwise, an artificial intelligence technology-based clinical imaging services provider, has raised $17.3 million in a series A plus round led by Danhua Capital.

Other investors in the round include Dalton Venture, FengHe Group, Tendence Capital, Kinzon Capital and Beijing Dongfang Hongdao Asset Management.

This round came after it secured RMB35 million series A in September. The investors were not disclosed.

The company focuses on developing clinical imaging diagnosis system for early-stage detection of breast cancer, prostate cancer and chest radiograph.

WeDoctor invests in Halove

WeDoctor Group, an online healthcare service provider, has participated in a $31.6 million series A round in Halove (Hangzhou) Technology, a Chinese hardware and healthcare software developer.

Halove provides smart phones, visual reality headset and wearable devices. Its healthcare platform offers 24-hour emergency rescue system, online private doctor and health index monitoring.

WeDoctor, which was created in 2010, has become one of the world’s largest medical guidance and heath consultation provider through mobile application and Guahao online portal.

WeDoctor has so far raised a total funding of $520.5 million. Its investors included Tencent Holdings, Qiming Venture Partners, Goldman Sachs, Fosun Group and Hillhouse Capital.

Also read:

JPMorgan sees China deals heating up as wait-and-see period ends

China Digest: Malong raises $33m Series B from SBCVC; gets $31m

China: Fosun High Tech chairman to leave post, remain at parent